{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-003910","form_type":"8-K","ticker":"BCRX","cik":"0000882796","company_name":"BIOCRYST PHARMACEUTICALS INC","filed_at":"2025-06-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.584826+00:00","generated_at":"2026-05-19T07:22:12.244710+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"BioCryst shareholders approve 11M share increase in stock incentive plan at annual meeting","bullets":["Director George Abercrombie retired effective June 12, 2025 after 13 years; no disagreement cited.","Shareholders approved amended Stock Incentive Plan, increasing shares available by 11,000,000 to 81,090,000 total.","Advisory say-on-pay passed with 143.1M for vs 6.4M against; auditor Ernst & Young ratified with 174.7M for.","Director nominees Steven Galson and Alan Levin re-elected with ~146M votes each."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-003910","json":"https://secwatch.observer/filing/0001171843-25-003910.json","markdown":"https://secwatch.observer/filing/0001171843-25-003910.md","text":"https://secwatch.observer/filing/0001171843-25-003910.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/882796/000117184325003910/0001171843-25-003910-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/882796/000117184325003910/f8k_061625.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T07:22:12.244710+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b8a7097581","claim":"George B. Abercrombie retired as Director at BIOCRYST PHARMACEUTICALS INC.","evidence_excerpt":"On June 11, 2025, George B. Abercrombie notified BioCryst Pharmaceuticals, Inc., a Delaware corporation (the “Company”), of his intention to retire from the Board of Directors of the Company (the “Board”), effective as of the Company’s 2025 Annual Meeting of Stockholders (the “Annual Meeting”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/882796/000117184325003910/0001171843-25-003910-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}